Evaluation of the VersaTREK System Compared to the Bactec MGIT 960 System for First-line Drug Susceptibility Testing of Mycobacterium Tuberculosis

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 2011 Dec 3

PMID 22135258

Citations 9

Authors

M Espasa

M Salvado

E Vicente

G Tudo

F Alcaide

P Coll

N Martin-Casabona

M Torra

D Fontanals

J Gonzalez-Martin

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to evaluate the reliability of the VersaTREK system for Mycobacterium tuberculosis drug susceptibility testing compared with results obtained with the Bactec MGIT 960 system. A total of 67 strains were evaluated. Overall agreement was at 98.5%. Kappa indexes were 1.0 for isoniazid, rifampin, and ethambutol, 0.937 for pyrazinamide, and 0.907 for streptomycin. The VersaTREK system is validated for M. tuberculosis drug susceptibility testing.

Citing Articles

Impacts of MDR/XDR-TB on the global tuberculosis epidemic: Challenges and opportunities.

Chin K, Anibarro L, Chang Z, Palasuberniam P, Mustapha Z, Sarmiento M Curr Res Microb Sci. 2024; 7:100295.

PMID: 39512261 PMC: 11541417. DOI: 10.1016/j.crmicr.2024.100295.

Advances in TB testing.

Pagaduan J, Altawallbeh G Adv Clin Chem. 2023; 115:33-62.

PMID: 37673521 PMC: 10056534. DOI: 10.1016/bs.acc.2023.03.003.

Improved Conventional and New Approaches in the Diagnosis of Tuberculosis.

Dong B, He Z, Li Y, Xu X, Wang C, Zeng J Front Microbiol. 2022; 13:924410.

PMID: 35711765 PMC: 9195135. DOI: 10.3389/fmicb.2022.924410.

Tuberculosis in the Elderly.

Caraux-Paz P, Diamantis S, de Wazieres B, Gallien S J Clin Med. 2021; 10(24).

PMID: 34945187 PMC: 8703289. DOI: 10.3390/jcm10245888.

GeneChip analysis of resistant Mycobacterium tuberculosis with previously treated tuberculosis in Changchun.

Zhang M, Ren W, Sun X, Liu Y, Liu K, Ji Z BMC Infect Dis. 2018; 18(1):234.

PMID: 29788948 PMC: 5964880. DOI: 10.1186/s12879-018-3131-8.

References

Bemer P, Palicova F, Rusch-Gerdes S, Drugeon H, Pfyffer G . Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol. 2002; 40(1):150-4. PMC: 120114. DOI: 10.1128/JCM.40.1.150-154.2002. View

LaBombardi V . Comparison of the ESP and BACTEC systems for testing susceptibilities of Mycobacterium tuberculosis complex isolates to pyrazinamide. J Clin Microbiol. 2002; 40(6):2238-9. PMC: 130663. DOI: 10.1128/JCM.40.6.2238-2239.2002. View

Ganeswrie R, Chui C, Balan S, Puthucheary S . Comparison of BACTEC MGIT 960 system and BACTEC 460 TB system for growth and detection of Mycobacteria from clinical specimens. Malays J Pathol. 2005; 26(2):99-103. View

Delas M, Martinez C, Yague C, Rodriguez T, Segovia M . [Comparative study of 3 tests for susceptibility of Mycobacterium tuberculosis to first-line antituberculous drugs]. Rev Esp Quimioter. 2001; 14(1):40-6. View

Roberts G, Goodman N, Heifets L, LARSH H, Lindner T, McClatchy J . Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol. 1983; 18(3):689-96. PMC: 270876. DOI: 10.1128/jcm.18.3.689-696.1983. View

Bergmann J, Woods G . Evaluation of the ESP culture system II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs. J Clin Microbiol. 1998; 36(10):2940-3. PMC: 105091. DOI: 10.1128/JCM.36.10.2940-2943.1998. View

Falzon D, Jaramillo E, Schunemann H, Arentz M, Bauer M, Bayona J . WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J. 2011; 38(3):516-28. DOI: 10.1183/09031936.00073611. View

Piersimoni C, Olivieri A, Benacchio L, Scarparo C . Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems. J Clin Microbiol. 2006; 44(1):20-8. PMC: 1351976. DOI: 10.1128/JCM.44.1.20-28.2006. View

Scarparo C, Ricordi P, Ruggiero G, Piccoli P . Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method. J Clin Microbiol. 2004; 42(3):1109-14. PMC: 356895. DOI: 10.1128/JCM.42.3.1109-1114.2004. View

10.

Wright A, Zignol M, Van Deun A, Falzon D, Gerdes S, Feldman K . Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet. 2009; 373(9678):1861-73. DOI: 10.1016/S0140-6736(09)60331-7. View

11.

Garrigo M, Aragon L, Alcaide F, Borrell S, Cardenosa E, Galan J . Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol. 2007; 45(6):1766-70. PMC: 1933104. DOI: 10.1128/JCM.02162-06. View

12.

Tortoli E, Benedetti M, Fontanelli A, Simonetti M . Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion. J Clin Microbiol. 2002; 40(2):607-10. PMC: 153389. DOI: 10.1128/JCM.40.2.607-610.2002. View

13.

Laszlo A, Rahman M, Espinal M, Raviglione M . Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998. Int J Tuberc Lung Dis. 2002; 6(9):748-56. View

14.

Ardito F, Posteraro B, Sanguinetti M, Zanetti S, Fadda G . Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol. 2001; 39(12):4440-4. PMC: 88562. DOI: 10.1128/JCM.39.12.4440-4444.2001. View

15.

Abdel Aziz M, Wright A, Laszlo A, De Muynck A, Portaels F, Van Deun A . Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet. 2006; 368(9553):2142-54. DOI: 10.1016/S0140-6736(06)69863-2. View

16.

Tarrand J, Groschel D . Evaluation of the BACTEC radiometric method for detection of 1% resistant populations of Mycobacterium tuberculosis. J Clin Microbiol. 1985; 21(6):941-6. PMC: 271822. DOI: 10.1128/jcm.21.6.941-946.1985. View

17.

Ruiz P, Zerolo F, Casal M . Comparison of susceptibility testing of Mycobacterium tuberculosis using the ESP culture system II with that using the BACTEC method. J Clin Microbiol. 2000; 38(12):4663-4. PMC: 87660. DOI: 10.1128/JCM.38.12.4663-4664.2000. View